BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sigalov AB. Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation. Front Immunol 2020;11:173. [PMID: 32117302 DOI: 10.3389/fimmu.2020.00173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Siskind S, Brenner M, Wang P. TREM-1 Modulation Strategies for Sepsis. Front Immunol 2022;13:907387. [DOI: 10.3389/fimmu.2022.907387] [Reference Citation Analysis]
2 Muller M, Haghnejad V, Lopez A, Tiotiu A, Renaud S, Derive M, Bronowicki J. Triggering Receptors Expressed on Myeloid Cells 1 : Our New Partner in Human Oncology? Front Oncol 2022;12:927440. [DOI: 10.3389/fonc.2022.927440] [Reference Citation Analysis]
3 Zhong WJ, Duan JX, Liu T, Yang HH, Guan XX, Zhang CY, Yang JT, Xiong JB, Zhou Y, Guan CX, Li Q. Activation of NLRP3 inflammasome up-regulates TREM-1 expression in murine macrophages via HMGB1 and IL-18. Int Immunopharmacol 2020;89:107045. [PMID: 33045564 DOI: 10.1016/j.intimp.2020.107045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Thankam FG, Sanchez DJ, Agrawal DK. Design of the lentivirus-driven sustained LR12 delivery system for TREM-1 inhibition for palliating atherosclerosis. Mol Cell Biochem 2022. [PMID: 35001222 DOI: 10.1007/s11010-021-04321-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]